We use cookies to improve your website experience. To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy. By continuing to use the website, you consent to our use of cookies. Close

Avoiding a catch-22

Intellectual Property Magazine

Avoiding a catch-22

Dykema’s Tania Shapiro-Barr and Mark Mansour explore how to navigate FDA approval and patent protection in the medical device world

Regulatory approval and patent protectionare key milestones for the success of any medical device. While most applicants have an understanding of the US Food and DrugAdministration’s (FDA) 510(k) regulatory pathway for the clearance of medicaldevices, there is less information available regarding how to avoid commonpitfalls during the process. This section will discuss some of these, with tipson how to avoid them.

The rest of this document is only available to i-law.com online subscribers.

If you are already a subscriber, please enter your details below to log in.

Enter your email address to log in as a user on your corporate account.
Remember me on this computer

Not yet an i-law subscriber?


Request a trial Find out more